# PRD Quality Review — Medi

## Overall verdict

Good draft for whole-product planning and staged synthetic development, with no critical or high findings. It reconciles the existing outpatient slice with a serious commercial hospital product and explicitly prevents unsupported services from being treated as delivered. A few source requirements lose testable detail; restore those before deriving affected stories, while clinical, commercial and deployment decisions correctly remain open.

Reviewed `prd.md`, `addendum.md`, `input-extract.md` against the BMad PRD quality rubric on 2026-10-13. This review assesses draft/partial planning quality, not clinical or production release approval; no new research or code validation was performed.

## Decision-readiness — strong

Sections 6 and 8 name staged release evidence, decision owners and concrete triggers. D02/D07/D08 separate deployment, data governance and operating commitments, avoiding a premature provider decision. Owner roles are explicitly unfilled accountability slots rather than fabricated recruited specialists. The addendum explains that local PostgreSQL already supports development and optional Supabase is not a migration decision.

The inpatient prerequisite is explicit: §6 H1 says any module required by a pilot facility must be delivered before that pilot regardless of the table's sequence; FR-22 disallows claiming inpatient coverage from a bed board and outpatient notes. D01 must establish actual facility coverage before the pilot backlog or sales promises. No finding is warranted for deliberately leaving these real customer decisions unresolved.

## Substance over theater — strong

UJ-1–UJ-4 are clearly fictional scenarios and drive identity, handoff, correction and operational requirements. NFR-02 gives retry/conflict/recovery cases; NFR-06 makes workload and numeric thresholds a pre-pilot decision rather than inventing capacity. The text makes no novelty, confirmed demand, compliance or real-payment claims. Operational and clinical decision lists are necessary to this product's stakes.

## Strategic coherence — adequate

The thesis is accountable patient and financial handoffs across isolated customer organizations. FR-01–FR-28 develop that thesis into records, stock, finance and repeatable operation. A1/A4 visibly label outpatient-first usefulness and sequence as assumptions, while the H1 prerequisite prevents that sequence from silently excluding required hospital services. SM-01–SM-05 and their counter-measures assess outcomes rather than logins or screen counts. Commercial usefulness remains appropriately unvalidated under D01/D10.

## Done-ness clarity — adequate

Every FR has a verifiable acceptance consequence, and synthetic baseline versus target capability is mostly precise. Some candidate-requirement details have been generalized enough that an implementation satisfying this PRD could still miss its source intent.

### Findings

- **medium** Diagnostics lose explicit handoff and historical report guarantees (§4 FR-12/13; source R06, R08, R09) — The PRD covers specimen rejection and corrected results, but does not expressly require destination acknowledgement/pending-versus-received state, historically preserved test-definition/reference information, external report source/date, or a new review task after correction. Merely seeing a change is weaker than accountable follow-up. *Fix:* add these explicit consequences to FR-12/13 or mark each as deliberately deferred with an owner and trigger.
- **medium** Downtime recovery lacks a complete reconciliation consequence (§4 FR-27; source R15) — Preserving author and event time leaves entry time, assigned reconciliation owner, and duplicate paper-transaction detection unspecified. NFR-02 covers retried electronic requests but does not necessarily detect a second entry of the same paper transaction under a new request identity. *Fix:* require occurrence/entry timestamps, reconciliation ownership and duplicate downtime-entry handling in FR-27 acceptance.

## Scope honesty — strong

Section 3 differentiates implemented synthetic, partial and proposed work. FR-10 explicitly states that immutable closed visits do not deliver amendments; FR-15 distinguishes synthetic fulfillment from real dispensing. FR-21–23 and H1 expose the inpatient/specialist gap and the prerequisite for customers requiring those services. Ten open decisions and four assumptions fit the expressly draft/partial scope; they would block a broad live release approval, but do not invalidate a planning artifact.

## Downstream usability — adequate

The glossary and stable FR/UJ/SM/NFR/D identifiers support UX, architecture and story extraction. Source references and `input-extract.md` distinguish evidence from implementation. `reconcile-inputs.md` supplies the grouped R01–R24 mapping missing from the main narrative without bloating the PRD.

### Findings

- **low** Departmental operational reports lose specificity (§4 FR-24; source R19) — Generic operational/clinical reports and reconciled totals do not expressly promise unfinished handoffs, waiting versus service duration, incomplete records or aged reconciliation differences. *Fix:* list these intended report outcomes or record their package-specific disposition under D01/D08 before reporting stories are generated.

## Shape fit — strong

This is a brownfield, multi-role commercial product with substantial new scope. The combination of fictional role journeys, implemented/partial/proposed labels, whole-product requirements, release gates and separate implementation addendum fits that shape. It does not require inventing specialist clinical protocols to appear complete. The latest user intent for a serious real product is reflected without presenting today's synthetic slice as deployable hospital software.

## Mechanical notes

- FR-01–28, NFR-01–08, UJ-1–4, SM-01–5 and D01–10 appear contiguous and unique. A1–A4 each appear inline and in the assumptions index.
- Each UJ names its fictional actors; no fabricated interview is implied.
- Organization/facility terminology is consistent, with glossary links to customer isolation and physical locations.
- Relative repository links have consistent paths by inspection; this review did not revalidate every linked file or execute application checks.
- Three findings remain: two medium and one low. None blocks retaining this document as draft/partial. Acceptance of the affected delivery scope should resolve the noted source-detail gaps.

## Author disposition

All three findings were addressed in the draft on 2026-10-13: FR-12/13 now specify order acknowledgement, stable test-definition context, external provenance and a fresh review task after correction; FR-27 specifies entry time, reconciliation ownership and duplicate detection; FR-24 names the initial operational report outputs. No clinical policy or production approval was inferred.
